The complexity of neuroinflammation consequent to traumatic brain injury

from research evidence to potential treatments

Maria Cristina Morganti-Kossmann, Bridgette D. Semple, Sarah C. Hellewell, Nicole Bye, Jenna M. Ziebell

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

This review recounts the definitions and research evidence supporting the multifaceted roles of neuroinflammation in the injured brain following trauma. We summarise the literature fluctuating from the protective and detrimental properties that cytokines, leukocytes and glial cells play in the acute and chronic stages of TBI, including the intrinsic factors that influence cytokine responses and microglial functions relative to genetics, sex, and age. We elaborate on the pros and cons that cytokines, chemokines, and microglia play in brain repair, specifically neurogenesis, and how such conflicting roles may be harnessed therapeutically to sustain the survival of new neurons. With a brief review of the clinical and experimental findings demonstrating early and chronic inflammation impacts on outcomes, we focus on the clinical conditions that may be amplified by neuroinflammation, ranging from acute seizures to chronic epilepsy, neuroendocrine dysfunction, dementia, depression, post-traumatic stress disorder and chronic traumatic encephalopathy. Finally, we provide an overview of the therapeutic agents that have been tested to reduce inflammation-driven secondary pathological cascades and speculate the future promise of alternative drugs.

Original languageEnglish
Pages (from-to)731-755
Number of pages25
JournalActa Neuropathologica
Volume137
Issue number5
DOIs
Publication statusPublished - 1 May 2018

Cite this

@article{30230dddd4e540898c9da56256e0051a,
title = "The complexity of neuroinflammation consequent to traumatic brain injury: from research evidence to potential treatments",
abstract = "This review recounts the definitions and research evidence supporting the multifaceted roles of neuroinflammation in the injured brain following trauma. We summarise the literature fluctuating from the protective and detrimental properties that cytokines, leukocytes and glial cells play in the acute and chronic stages of TBI, including the intrinsic factors that influence cytokine responses and microglial functions relative to genetics, sex, and age. We elaborate on the pros and cons that cytokines, chemokines, and microglia play in brain repair, specifically neurogenesis, and how such conflicting roles may be harnessed therapeutically to sustain the survival of new neurons. With a brief review of the clinical and experimental findings demonstrating early and chronic inflammation impacts on outcomes, we focus on the clinical conditions that may be amplified by neuroinflammation, ranging from acute seizures to chronic epilepsy, neuroendocrine dysfunction, dementia, depression, post-traumatic stress disorder and chronic traumatic encephalopathy. Finally, we provide an overview of the therapeutic agents that have been tested to reduce inflammation-driven secondary pathological cascades and speculate the future promise of alternative drugs.",
author = "Morganti-Kossmann, {Maria Cristina} and Semple, {Bridgette D.} and Hellewell, {Sarah C.} and Nicole Bye and Ziebell, {Jenna M.}",
year = "2018",
month = "5",
day = "1",
doi = "10.1007/s00401-018-1944-6",
language = "English",
volume = "137",
pages = "731--755",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer-Verlag London Ltd.",
number = "5",

}

The complexity of neuroinflammation consequent to traumatic brain injury : from research evidence to potential treatments. / Morganti-Kossmann, Maria Cristina; Semple, Bridgette D.; Hellewell, Sarah C.; Bye, Nicole; Ziebell, Jenna M.

In: Acta Neuropathologica, Vol. 137, No. 5, 01.05.2018, p. 731-755.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - The complexity of neuroinflammation consequent to traumatic brain injury

T2 - from research evidence to potential treatments

AU - Morganti-Kossmann, Maria Cristina

AU - Semple, Bridgette D.

AU - Hellewell, Sarah C.

AU - Bye, Nicole

AU - Ziebell, Jenna M.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - This review recounts the definitions and research evidence supporting the multifaceted roles of neuroinflammation in the injured brain following trauma. We summarise the literature fluctuating from the protective and detrimental properties that cytokines, leukocytes and glial cells play in the acute and chronic stages of TBI, including the intrinsic factors that influence cytokine responses and microglial functions relative to genetics, sex, and age. We elaborate on the pros and cons that cytokines, chemokines, and microglia play in brain repair, specifically neurogenesis, and how such conflicting roles may be harnessed therapeutically to sustain the survival of new neurons. With a brief review of the clinical and experimental findings demonstrating early and chronic inflammation impacts on outcomes, we focus on the clinical conditions that may be amplified by neuroinflammation, ranging from acute seizures to chronic epilepsy, neuroendocrine dysfunction, dementia, depression, post-traumatic stress disorder and chronic traumatic encephalopathy. Finally, we provide an overview of the therapeutic agents that have been tested to reduce inflammation-driven secondary pathological cascades and speculate the future promise of alternative drugs.

AB - This review recounts the definitions and research evidence supporting the multifaceted roles of neuroinflammation in the injured brain following trauma. We summarise the literature fluctuating from the protective and detrimental properties that cytokines, leukocytes and glial cells play in the acute and chronic stages of TBI, including the intrinsic factors that influence cytokine responses and microglial functions relative to genetics, sex, and age. We elaborate on the pros and cons that cytokines, chemokines, and microglia play in brain repair, specifically neurogenesis, and how such conflicting roles may be harnessed therapeutically to sustain the survival of new neurons. With a brief review of the clinical and experimental findings demonstrating early and chronic inflammation impacts on outcomes, we focus on the clinical conditions that may be amplified by neuroinflammation, ranging from acute seizures to chronic epilepsy, neuroendocrine dysfunction, dementia, depression, post-traumatic stress disorder and chronic traumatic encephalopathy. Finally, we provide an overview of the therapeutic agents that have been tested to reduce inflammation-driven secondary pathological cascades and speculate the future promise of alternative drugs.

UR - http://www.scopus.com/inward/record.url?scp=85058013187&partnerID=8YFLogxK

U2 - 10.1007/s00401-018-1944-6

DO - 10.1007/s00401-018-1944-6

M3 - Review Article

VL - 137

SP - 731

EP - 755

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 5

ER -